Full article view 2017-03-17T14:47:35+00:00
Back to News & Insights »

Perspective: Convergence of CLIA and FDA Requirements: A Rationale Shift in the Regulatory Paradigm

The laboratory developed test (LDT) has proven to be a flexible, quick, lower-investment assay commercialization option—yet the evolving regulatory landscape still threatens to alter that. How can you navigate these tougher requirements while maximizing efficiencies? This brief will help you plan and prepare, ensuring that your quality systems and validation studies support FDA and CLIA requirements as they evolve—and that you stay a step ahead of regulatory demands.

Get the brief